• 1
    International Diabetes Foundation. Diabetes e-atlas, 2004. Accessed 20/06/06.
  • 2
    Kinmonth AL, Griffin S, Wareham NJ (1999) Implications of the United Kingdom Prospective Diabetes Study for general practice care of type 2 diabetes. British Journal of General Practice, 49, 692694.
  • 3
    UKPDS (1998) UK Prospective Diabetes Study 33: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352, 837853.
  • 4
    UKPDS (1998) UK Prospective Diabetes Study 34: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet, 352, 854865.
  • 5
    UKPDS. (1998) UK Prospective Diabetes Study 38: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ, 317, 703713.
  • 6
    Vermeire E, Van Royen P, Coenen S et al. (1999) Insulin and type 2 diabetes. Australian Family Physician, 28, 990.
  • 7
    Wens J, Vermeire E, Driel MV (1999) The United Kingdom Prospective Diabetes Study Group: onderzoeksopzet. Minerva, 2, 122124.
  • 8
    Goyder E, Irwig L (1998) Screening for diabetes: what are we really doing? BMJ, 317, 16441646.
  • 9
    Vermeire E, Hearnshaw H, Royen PV et al. (2001) Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics, 26, 331342.
  • 10
    Nagasawa N, Smith M, Barnes J et al. (1990) Meta-analysis of correlates of diabetes patients’ compliance with prescribed medications. The Diabetes Educator, 16, 192200.
  • 11
    Cramer JA (2004) A systematic review of adherence with medications for diabetes. Diabetes Care, 27, 12181224.
  • 12
    ASHP (1999) American Society of Health System Pharmacists statement on the pharmacist's role in primary care. American Journal of Health-System Pharmacy, 56, 16651667.
  • 13
    Department of Health. (2003) National service framework for diabetes: delivery strategy. London: Department of Health.
  • 14
    RPSGB (2001) Practice Guidance for Community Pharmacists on the Care of People with Diabetes. London: The Royal Pharmaceutical Society of Great Britain.
  • 15
    Wermeille J, Bennie M, Brown I et al. (2004) Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team-a pilot study. Pharmacy World and Science, 26, 1825.
  • 16
    Timmer JW, De Smet PAGM, Schuling J et al. (1999) Patient education to users of oral hypoglycemic agents: the perspective of Dutch community pharmacists. Pharmacy World and Science, 21, 200204.
  • 17
    Nichols-English GJ, Provost M, Koompalum D et al. (2002) Strategies for pharmacists in the implementation of diabetes mellitus management programs – new roles in primary and collaborative care. Disease Management and Health Outcomes, 10, 783803.
  • 18
    Rybacki JJ (2002) Improving cardiovascular health in postmenopausal women by addressing medication adherence issues. Journal of the American Pharmaceutical Association, 42, 6371.
  • 19
    Bunting B (2005) An opportunity for our profession: what pharmacists should know about disease management. Journal of the Pharmacy Society of Wisconsin, 2005, 810.
  • 20
    Carter BL, Zillich AJ, Elliott WJ (2003) How pharmacists can assist physicians with controlling blood pressure. Journal of Clinical Hypertension, 5, 3137.
  • 21
    Choe HM, Mitrovich S, Dubay D et al. (2005) Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. The American Journal of Managed Care, 11, 253260.
  • 22
    Irons BK, Lenz RJ, Anderson SL et al. (2002) A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy, 22, 12941300.
  • 23
    Rothman R, Malone R, Bryant B et al. (2003) Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. American Journal of Medical Quality, 18, 5158.
  • 24
    Odegard PS, Goo A, Hummel J et al. (2005) Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Annals of Pharmacotherapy, 39, 433440.
  • 25
    Coast-Senior EA, Kroner BA, Kelley CL et al. (1998) Management of patients with type 2 diabetes by pharmacists in primary care clinics. Annals of Pharmacotherapy, 32, 636641.
  • 26
    Davidson MB (2000) Effect of a pharmacist-managed diabetes care program in a free medical clinic. American Journal of Medical Quality, 15, 137142.
  • 27
    Jaber LA (1996) Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy, 30, 238243.
  • 28
    Matsuyama JR (1993) Pharmacists’ interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Annals of Pharmacotherapy, 27, 851855.
  • 29
    Skaer TL, Sclar DA, Markowski DJ et al. (1993) Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures – a study of patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Pharmacy and Therapeutics, 18, 295299.
  • 30
    Vermeire E, Wens J, Van Royen P et al. (2005) Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev CD003638, 18.
  • 31
    Roter D, Hall J, Merisca R et al. (1998) Effectiveness of interventions to improve patient compliance: a meta-analysis. Medical Care, 36, 11381161.
  • 32
    Gentili P, Maldonato A, Grieco R et al. (2001) Influence of patients’ representations and beliefs about diabetes and its treatment to their adherence to therapy. Diabetes Nutrition and Metabolism, 14, 140152.
  • 33
    Hearnshaw H, Lindenmeyer A (2005) What do we mean by adherence to treatment and advice for living with diabetes? a review of the literature on definitions and measurements. Diabetic Medicine, 23, 720728. doi: 10.1111/j.1464-5491.2005.01783.x
  • 34
    Toljamo M, Hentinen M (2001) Adherence to self-care and social support. Journal of Clinical Nursing, 10, 618627.
  • 35
    Lawton J, Ahmad N, Hallowell N et al. (2005) Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study. BMJ, 330, 1247.
  • 36
    Grant RW, Devita NG, Singer DE et al. (2003) Improving adherence and reducing medication discrepancies in patients with diabetes. Annals of Pharmacotherapy, 37, 962969.
  • 37
    Gafarian CT, Heiby EM, Blair P et al. (1999) The Diabetes time Management Questionnaire. The Diabetes Educator, 25, 585592.
  • 38
    Hernandez C (1997) The development and pilot testing of The Diabetes Activity Questionnaire (TDAQ): an instrument to measure adherence to the diabetes regimen. Applied Nursing Research, 10, 202211.
  • 39
    Greco P, La Greca A, Auslander W et al. (1990) Assessing adherence in IDDM: A comparison of two methods. Diabetes, 40, 108A.
  • 40
    Kyngäs H, Duffy M, Kroll T (2000) Conceptual analysis of compliance. Journal of Clinical Nursing, 9, 512.
  • 41
    Reach G (2005) Role of habit in adherence to medical treatment. Diabetic Medicine, 22, 415420.
  • 42
    Garrett DG, Martin LA (2003) The Asheville Project: participants’ perceptions of factors contributing to the success of a patient self-management diabetes program. Journal of the American Pharmaceutical Association (Washington, DC), 43, 185190.
  • 43
    Cranor CW, BUnting BA, Christensen DB (2003) The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. Journal of the American Pharmaceutical Association (Washington, DC), 43, 173184.
  • 44
    Hawe P, Shiell A, Riley T (2004) Complex interventions: how ‘out of control’ can a randomised controlled trial be? BMJ, 328, 15611563.
  • 45
    Lindsay B (2004) Randomized controlled trials of socially complex nursing interventions: creating bias and unreliability? Journal of Advanced Nursing, 45, 8494.
  • 46
    MRC (2000) A framework for development and evaluation of RCTs for complex interventions to improve health. London: Medical Research Council.